[Federal Register Volume 63, Number 98 (Thursday, May 21, 1998)]
[Notices]
[Page 27916]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-13571]
========================================================================
Notices
Federal Register
________________________________________________________________________
This section of the FEDERAL REGISTER contains documents other than rules
or proposed rules that are applicable to the public. Notices of hearings
and investigations, committee meetings, agency decisions and rulings,
delegations of authority, filing of petitions and applications and agency
statements of organization and functions are examples of documents
appearing in this section.
========================================================================
Federal Register / Vol. 63, No. 98 / Thursday, May 21, 1998 /
Notices
[[Page 27916]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF AGRICULTURE
Animal and Plant Health Inspection Service
[Docket No. 98-050-1]
Availability of an Environmental Assessment and Finding of No
Significant Impact for Field Testing Edwardsiella Ictaluri Vaccine
AGENCY: Animal and Plant Health Inspection Service, USDA.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: We are advising the public that the Animal and Plant Health
Inspection Service has prepared an environmental assessment and finding
of no significant impact concerning authorization to ship for the
purpose of field testing and the field testing of an unlicensed live
bacterial vaccine for use in catfish. A risk analysis, which forms the
basis for the environmental assessment, has led us to conclude that
field testing this veterinary vaccine will not have a significant
impact on the quality of the human environment. Based on our finding of
no significant impact, we have determined that an environmental impact
statement need not be prepared. With this notice, we state our
intention to authorize shipment of this vaccine for field testing 14
days after the date of this notice, unless new substantial issues
bearing on the effects of the action contemplated here are brought to
our attention. We also state our intention to issue a veterinary
biological product license for this vaccine, provided the field test
data support the conclusions of the environmental assessment and
finding of no significant impact and the product meets all other
requirements for licensure.
ADDRESSES: Copies of the environmental assessment and finding of no
significant impact may be obtained by contacting the person listed
under FOR FURTHER INFORMATION CONTACT. Please refer to the docket
number, date, and complete title of this notice when requesting copies.
Copies of the environmental assessment and finding of no significant
impact (as well as the risk analysis with confidential business
information removed) are available for public inspection at USDA, room
1141, South Building, 14th Street and Independence Avenue SW.,
Washington, DC, between 8 a.m. and 4:30 p.m., Monday through Friday,
except holidays. Persons wishing to inspect those documents are
requested to call ahead on (202) 690-2817 to facilitate entry into the
reading room.
FOR FURTHER INFORMATION CONTACT: Dr. Jeanette Greenberg, Technical
Writer- Editor, Center for Veterinary Biologics, Licensing and Policy
Development, VS, APHIS, USDA, 4700 River Road Unit 148, Riverdale, MD
20737-1231; telephone (301) 734-5338; fax (301) 734-4314; e-mail
jgreenberg@aphis.usda.gov.
SUPPLEMENTARY INFORMATION: Under the Virus-Serum-Toxin Act (21 U.S.C.
151 et seq.), a veterinary biological product must be shown to be pure,
safe, potent, and efficacious before a veterinary biological product
license may be issued. A field test is generally necessary to satisfy
prelicensing requirements for veterinary biological products. Prior to
conducting a field test on an unlicensed product, an applicant must
obtain approval from the Animal and Plant Health Inspection Service
(APHIS), as well as obtain APHIS' authorization to ship the product for
field testing.
In determining whether to authorize shipment and grant approval for
the field testing of the unlicensed product referenced in this notice,
APHIS conducted a risk analysis to assess the potential effects of this
product on the safety of animals, public health, and the environment.
Based on the risk analysis, APHIS has prepared an environmental
assessment (EA). APHIS has concluded that field testing the unlicensed
veterinary biological product will not significantly affect the quality
of the human environment. Based on this finding of no significant
impact (FONSI), we have determined that there is no need to prepare an
environmental impact statement.
An EA and FONSI have been prepared by APHIS concerning the field
testing of the following unlicensed veterinary biological product:
Requester: Alpharma NW Inc.
Product: Edwardsiella Ictaluri Vaccine, Avirulent Live Culture,
Code 1531.R0.
Field test locations: Arkansas, Louisiana, and Mississippi.
The above-mentioned product is an aroA gene-deleted bacterial
vaccine for use as an aid in preventing enteric septicemia in channel
catfish.
The EA and FONSI have been prepared in accordance with: (1) The
National Environmental Policy Act of 1969, as amended (NEPA) (42 U.S.C.
4321 et seq.), (2) regulations of the Council on Environmental Quality
for implementing the procedural provisions of NEPA (40 CFR parts 1500-
1508), (3) USDA regulations implementing NEPA (7 CFR part 1b), and (4)
APHIS NEPA Implementing Procedures (7 CFR part 372).
Unless substantial environmental issues are raised in response to
this notice, APHIS intends to authorize shipment of the above product
for the initiation of field tests 14 days from the date of this notice.
Because the issues raised by field testing and by issuance of a
license are identical, APHIS has concluded that the EA and FONSI that
were generated for field testing would also be applicable to the
proposed licensing action. Provided that the field test data support
the conclusions of the original EA and FONSI, APHIS does not intend to
issue a separate EA to support the issuance of the product license, and
would determine that an environmental impact statement need not be
prepared. APHIS intends to issue a veterinary biological product
license for this vaccine following completion of the field test
provided no adverse impacts on the human environment are identified and
provided the product meets all other requirements for licensure.
Authority: 21 U.S.C. 151-159.
Done in Washington, DC, this 15th day of May 1998.
Charles P. Schwalbe,
Acting Administrator, Animal and Plant Health Inspection Service.
[FR Doc. 98-13571 Filed 5-20-98; 8:45 am]
BILLING CODE 3410-34-P
